Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

The Outcome of Radioiodine Therapy for Graves’ Hyperthyroidism: a Single Institution Experience with Calculated Dose Regimen (CROSBI ID 714647)

Prilog sa skupa u časopisu | kratko priopćenje

Jukić, Tomislav ; Punda, Marija ; Vidranski, Valentina ; Franceschi, Maja ; Kusić, Zvonko The Outcome of Radioiodine Therapy for Graves’ Hyperthyroidism: a Single Institution Experience with Calculated Dose Regimen // European journal of nuclear medicine and molecular imaging. 2018. str. 114-115

Podaci o odgovornosti

Jukić, Tomislav ; Punda, Marija ; Vidranski, Valentina ; Franceschi, Maja ; Kusić, Zvonko

engleski

The Outcome of Radioiodine Therapy for Graves’ Hyperthyroidism: a Single Institution Experience with Calculated Dose Regimen

s: Iodine-131 therapy is effective treatment of GH. In pts with lower TGW (<20g), with this calculated dose approach, 100% cure rate was achieved with one RAIT. However, for larger glands, more than one RAIT was necessary to cure hyperthyroidism, especially for TGW>40g. Therefore, for large glands, ablative approach with 5, 92 -7, 4 MBq I-131/g of TGW should be advocated. No difference in median TGW decrease was observed between groups probably due to calculated approach

I-131 therapy, Graves’ hyperthyroidism

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

114-115.

2018.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

European journal of nuclear medicine and molecular imaging

Springer

1619-7070

1619-7089

Podaci o skupu

Annual Congress of the European Association of Nuclear Medicine (EANM)

poster

13.10.2018-17.10.2018

Düsseldorf, Njemačka

Povezanost rada

Kliničke medicinske znanosti